The Cholesterol Killer You’ve Never Heard Of
Eli Lilly’s new drug lepodisiran just did what no statin ever could—obliterate lipoprotein(a), a sneaky type of cholesterol that flies under the radar. In a small trial, a single shot crushed levels for nearly a year. That’s like disarming a heart attack waiting to happen. For folks with high stroke risk, this could be a game-changer, especially when standard tests and meds don’t even see it coming. Silent threat, meet your match.
#hearthealth #elililly #medicalbreakthrough #sciencewin #technology